401 related articles for article (PubMed ID: 23440818)
1. Intramuscular versus intravenous anti-D for preventing Rhesus alloimmunization during pregnancy.
Okwundu CI; Afolabi BB
Cochrane Database Syst Rev; 2013 Jan; (1):CD007885. PubMed ID: 23440818
[TBL] [Abstract][Full Text] [Related]
2. Anti-D administration after spontaneous miscarriage for preventing Rhesus alloimmunisation.
Karanth L; Jaafar SH; Kanagasabai S; Nair NS; Barua A
Cochrane Database Syst Rev; 2013 Mar; (3):CD009617. PubMed ID: 23543581
[TBL] [Abstract][Full Text] [Related]
3. Prevention of Rh alloimmunization.
Fung Kee Fung K; Eason E; Crane J; Armson A; De La Ronde S; Farine D; Keenan-Lindsay L; Leduc L; Reid GJ; Aerde JV; Wilson RD; Davies G; Désilets VA; Summers A; Wyatt P; Young DC;
J Obstet Gynaecol Can; 2003 Sep; 25(9):765-73. PubMed ID: 12970812
[TBL] [Abstract][Full Text] [Related]
4. Anti-D administration in pregnancy for preventing Rhesus alloimmunisation.
McBain RD; Crowther CA; Middleton P
Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD000020. PubMed ID: 26334436
[TBL] [Abstract][Full Text] [Related]
5. Anti-D administration in pregnancy for preventing Rhesus alloimmunisation.
Crowther CA; Middleton P; McBain RD
Cochrane Database Syst Rev; 2013 Feb; (2):CD000020. PubMed ID: 23450526
[TBL] [Abstract][Full Text] [Related]
6. [Prevention of fetomaternal rhesus-D allo-immunization. Practical aspects].
Cortey A; Brossard Y
J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S123-1S130. PubMed ID: 16495838
[TBL] [Abstract][Full Text] [Related]
7. [Spontaneous antepartal RhD alloimmunization].
Studničková M; Holusková I; Durdová V; Kratochvílová T; Strašilová P; Marková I; Lubušký M
Ceska Gynekol; 2015 Dec; 80(6):401-4. PubMed ID: 26741153
[TBL] [Abstract][Full Text] [Related]
8. Anti-D administration in pregnancy for preventing rhesus alloimmunisation.
Crowther CA; Keirse MJ
Cochrane Database Syst Rev; 2000; (2):CD000020. PubMed ID: 10796088
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of anti-D IgG in pregnant RhD-negative women.
Bichler J; Schöndorfer G; Pabst G; Andresen I
BJOG; 2003 Jan; 110(1):39-45. PubMed ID: 12504934
[TBL] [Abstract][Full Text] [Related]
10. [Prevention of Rh (D) alloimmunization in Rh (D) negative women in pregnancy and after birth of Rh (D) positive infant].
L'ubuský M; Procházka M; Krejcová L; Vetr M; Santavý J; Kudela M
Ceska Gynekol; 2006 May; 71(3):173-9. PubMed ID: 16768042
[TBL] [Abstract][Full Text] [Related]
11. The scientific basis of antenatal prophylaxis.
Urbaniak SJ
Br J Obstet Gynaecol; 1998 Nov; 105 Suppl 18():11-8. PubMed ID: 9863973
[TBL] [Abstract][Full Text] [Related]
12. Anti-D administration after childbirth for preventing Rhesus alloimmunisation.
Crowther C; Middleton P
Cochrane Database Syst Rev; 2000; 1997(2):CD000021. PubMed ID: 10796089
[TBL] [Abstract][Full Text] [Related]
13. [Guideline for prevention of RhD alloimmunizationin RhD negative women].
Lubušký M; Procházka M; Simetka O; Holusková I
Ceska Gynekol; 2013 Apr; 78(2):132-3. PubMed ID: 23710977
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness and costs of non-invasive foetal RHD genotyping in rhesus-D negative mothers: a French multicentric two-arm study of 850 women.
Darlington M; Carbonne B; Mailloux A; Brossard Y; Levy-Mozziconacci A; Cortey A; Maoulida H; Simon T; Rousseau A; Durand-Zaleski I;
BMC Pregnancy Childbirth; 2018 Dec; 18(1):496. PubMed ID: 30547830
[TBL] [Abstract][Full Text] [Related]
15. Routine administration of Anti-D: the ethical case for offering pregnant women fetal RHD genotyping and a review of policy and practice.
Kent J; Farrell AM; Soothill P
BMC Pregnancy Childbirth; 2014 Feb; 14():87. PubMed ID: 24568571
[TBL] [Abstract][Full Text] [Related]
16. Routine antenatal anti-D prophylaxis for RhD-negative women: a systematic review and economic evaluation.
Pilgrim H; Lloyd-Jones M; Rees A
Health Technol Assess; 2009 Feb; 13(10):iii, ix-xi, 1-103. PubMed ID: 19210896
[TBL] [Abstract][Full Text] [Related]
17. The kinetics of routine antenatal prophylactic intramuscular injections of polyclonal anti-D immunoglobulin.
MacKenzie IZ; Roseman F; Findlay J; Thompson K; Jackson E; Scott J; Reed M
BJOG; 2006 Jan; 113(1):97-101. PubMed ID: 16398777
[TBL] [Abstract][Full Text] [Related]
18. Prevention of RhD alloimmunization in RhD negative women.
Lubusky M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2010 Mar; 154(1):3-7. PubMed ID: 20445704
[TBL] [Abstract][Full Text] [Related]
19. Use of cffDNA to avoid administration of anti-D to pregnant women when the fetus is RhD-negative: implementation in the NHS.
Soothill PW; Finning K; Latham T; Wreford-Bush T; Ford J; Daniels G
BJOG; 2015 Nov; 122(12):1682-6. PubMed ID: 25142171
[TBL] [Abstract][Full Text] [Related]
20. Receipt of RhD-positive whole blood for life-threatening bleeding in female children: A survey in alloimmunized mothers regarding minimum acceptable survival benefit relative to risk of maternal alloimmunization to anti-D.
Sherwood MR; Clayton S; Leeper CM; Yazer M; Moise KJ; Granger ME; Spinella PC
Transfusion; 2024 May; 64 Suppl 2():S100-S110. PubMed ID: 38563495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
